Locus Biosciences Partners on Precision Eye Infection Therapy
October 28, 2025
Collaboration to develop engineered bacteriophage therapeutics targeting bacterial pathogens responsible for serious eye infections Locus Biosciences, a clinical-stage biotechnology company developing precision engineered bacteriophage treatments